<<
>>

СПИСОК ЛИТЕРАТУРЫ

1. Авдеев, С.Н. Пневмония и острый респираторный дистресс- синдром, вызванные вирусом гриппа А/НШ1 [Текст] / С.Н. Авде­ев // Пульмонология. - 2010. - Прил. «Грипп A/H1N1: уроки панде­мии».

- С. 32-46.

2. Авдеев, С.Н. Тяжелые формы пандемического гриппа A/H1N1 2009 [Текст] / С.Н. Авдеев // Атмосфера. Пульмонология и аллерго­логия. - 2010. - № 4. - С. 1-10.

3. Алексеев, А.М. Интенсивная терапия больных с тяжелым течением гриппа А(НШ1), осложненного пневмонией [Текст] /

А.М. Алексеев, О.В. Шупинский, К.Н. Храпов // Вестник анестезио­логии и реаниматологии. - 2009. - Т.6, № 6. - С. 35-39.

4. Андрейчиков, А.В. Детерминированность метаболического иммунодефицита при аномалиях положения почек: дис. ... д-ра мед. наук: 14.00.16 [Текст] / Андрейчиков Александр Владимирович. - Томск, 2003. - 202 с.

5. Внебольничная пневмония у взрослых: практические рекомен­дации по диагностике, лечению и профилактике [Текст] / Под ред. А.Г. Чучалина [и др.]. - М.: Атмосфера, 2014. - 45 с.

6. Грипп: эпидемиология, диагностика, лечение, профилактика [Текст] / Под редакцией акад. РАМН проф. О.И. Киселева, д-ра мед. наук Л.М. Цыбаловой, акад. РАМН проф. В.И. Покровского. - М.: ООО «Из­дательство «Медицинское информационное агентство», 2012. - 496 с.

7. Запольских, А.М. Особенности эпидемиологии и профилакти­ки пандемического гриппа в условиях мегаполиса: дис. ... канд. мед наук: 14.02.02 [Текст] / Запольских Анна Михайловна. - Москва, 2014. - 213 с.

8. Зарубаев, В.В. Использование индукторов апоптоза в терапии экспериментальной гриппозной инфекции и предотвращение хрони­ческих постгриппозных поражений легких [Текст] / В.В. Зарубаев // Цитология. - 2014. - Т. 56, № 3. - С. 241-247.

9. Использование прогностических математических моделей для выявления больных туберкулезом легких [Текст] / А.Н. Наркевич,

К.А. Виноградов, Н.М. Корецкая, А.А. Наркевич // Туберкулез и бо­лезни легких.

- 2014. - Т. 91, № 9. - С. 44-45.

10. Методические рекомендации по диагностике и лечению грип­па, утвержденные Министерством здравоохранения РФ. - Москва, М.: Издательство. - 2016. - 29 с.

11. Организация медицинской помощи при внебольнич- ных пневмониях, связанных с эпидемическим подъемом забо­леваемости гриппом и ОРВИ: метод. рекомендации для вра­чей / И.П. Артюхов, И.В. Демко, Е.Е. Корчагин [и др.]; под.ред. А.Г. Чучалина. М-во здравоохранения Краснояр. края, ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава Рос­сии. - М., 2016. - 108 с.

12. Особенности современного гриппа [Текст] / Н.А. Малышев, М.В. Базарова, Г.Н. Кареткина [и др.] // Туберкулез и социально­значимые забоевания. - 2014. - № 4. - С. 43-51.

13. Показатели воспалительных реакций, гемостаза и эндотели- оза при тяжелой пневмонии в зависимости от исходов заболевания и их сопряжение [Текст] / А.П. Момот, И.В. Балацкая, Т.И. Мар­тыненко и др. // Современные проблемы науки и образования. - 2014. - № 2. - С. 344.

14. Пульмонология: национальное руководство [Текст] / под ред. А.Г. Чучалина. - М.: ГЭОТАР-Медиа, 2014. - 800 с.

15. Романова, Е.Н. Пневмонии у больных гриппом А/НШ1/09: клинико-патогенетические закономерности и исходы: дис. ... д-ра мед. наук: 14.00.05 [Текст] / Романова Елена Николаевна. - Чита, 2014. - 314 с.

16. Савченко, А.А. Высокочувствительное определение активно­сти дегидрогеназ в лимфоцитах периферической крови человека био- люминесцентным методом [Текст] / А.А. Савченко, Л.Н. Сунцова // Лаб. дело. - 1989. - № 11. - С. 23-25.

17. Савченко, А.А. Метаболические особенности лимфоцитов крови у людей с нарушениями иммунореактивности, проживающих в разных климато-географических условиях: Автореф. дис. ... д-ра мед. наук [Текст] / А.А. Савченко. - Томск, 1996. - 30 с.

18. Савченко, А.А. Основы клинической иммунометаболоми- ки [Текст] / А.А. Савченко, А.Г. Борисов. - Новосибирск: Наука,

2012. - 263 с.

19. Савченко, А.А. Содержание АТФ и активность НАД(Ф)- зависимых дегидрогеназ в лимфоцитах при иммунодефицитассо- циированных заболеваниях у пришлых жителей Эвенкии [Текст] /

A.

А. Савченко, С.В. Смирнова, А.Г. Борисов // Бюлл. СО РАМН. - 2010. - Т. 30, № 3. - С. 33-38.

20. Симаненков, В.И. Внебольничная пневмония [Текст] / В.И. Си- маненков, Е.А. Лутаенко // Лечащий врач. - 2014. - № 11. - С. 112-114.

21. Федеральные клинические рекомендации Российского респи­раторного общества по диагностике и лечению тяжелых форм гриппа [Текст] / А.Г. Чучалин, С.Н. Авдеев, А.Л. Черняев [и др.] // Пульмо­нология. - 2014. - № 5. - С. 11-19.

22. Фесенко, О.В. Тяжелая внебольничная пневмония и шкалы оценки прогноза [Текст] / О.В. Фесенко, А.И. Синопальников // Практическая пульмонология. - 2014. - № 2. - С. 56-59.

23. Харитонов, М.А. Пневмонии [Текст] / М.А. Харитонов,

B. А. Андреев, Т.И. Оболенская // Медицинская лабораторная диа­гностика: программы и алгоритмы. - М.: ГОЭТАР-Медиа, 2014. - Гл. 15. - С. 430-458.

24. Чаванина, С.А. Клинико-патогенетические закономерности течения внебольничных пневмоний в период эпидемии гриппа А А/ H1N1/09 у детей: дис. ... канд. мед. наук: 14.01.08 [Текст] / Чаванина Светлана Александровна. - Хабаровск, 2014. - 142 с.

25. Чучалин, А.Г. Клинические рекомендации по диагностике, ле­чению и профилактике тяжелой внебольничной пневмонии у взрос­лых [Электронный ресурс] / А.Г. Чучалин // Российское респира­торное общество. - 2014. - Режим доступа: http://www.pulmonology. ru/publications/guide.php.

26. Чучалин А.Г. Пневмония: актуальная проблема медицины XXI века [Текст] / А.Г. Чучалин // Пульмонология. - 2015. - Т. 25, № 2. - С. 133-142.

27. Чучалин, А.Г. Пневмония: актуальная проблема медицины XXI века [Текст] / А.Г. Чучалин // Терапевтич. архив. - 2016. - Т. 88, № 3. - С. 4-12.

28. Эпидемический сезон 2013-2014 гг. Госпитальный монито­ринг и противовирусная терапия гриппа [Текст] / Л.В. Колобухина,

Е.И. Бурцева, М.Ю. Щелканов [и др.] // Терапевтический архив. - 2014. - Т. 86, № 10. - С. 52-59.

29. A case of severe ARDS caused by novel swine-origin influenza (A∕H1N1pdm) virus: a successful treatment with direct hemoperfusion with polymyxin В-immobilized fiber [Text] ∕ T Yokoyama [et al.] ∕∕

J.

Clin. Apher. - 2010. - Vol. 25 (6). - Р 350-353.

30. A Complicated Message: Identification of a Novel PB 1-Related Protein Translated from Influenza A Virus Segment 2 mRNA [Text] ∕ H.M. Wise, A. Foeglein, J. Sun [et al.] ∕∕ J. Virol. - 2009. - Vol. 83, № 16. - P. 8021-8031.

31. A novel risk factor for a novel virus: obesity and 2009 pandem­ic influenza A(H1N1) [Text] ∕ J.K. Louie, M. Acosta, M.C. Samuel [et al.] ∕∕ Clin. Infect. Dis. - 2011. - Vol. 52, N 3. - P. 301-312.

32. Adeola, O.A. Detection of pandemic strain of influenza virus (A∕H1N1∕pdm09) in pigs, West Africa: implications and considerations for prevention of future influenza pandemics at the source [Электронный ресурс] ∕ O.A. Adeola, B.O. Olugasa, B.O. Emikpe ∕∕ Infect Ecol Epide­miol. - 2015. - 5: 30227. - Режим доступа: httpι∕∕dx.doi.org∕10.3402∕ iee.v5.30227.

33. Agarwal, P.P. Chest radiographic and CT finings in novel swine­origin influenza A (HlNl) virus [Text] ∕ PP Agarwal, S. Sinti, E.A. Kaze- rooni ∕∕ Am. J. Roentgenol. - 2009. - P. 1488-1493.

34. Allen, S.J. Chemokine: receptorstructure, interactions, andantag- onism [Text] ∕ SJ. Allen, S.E. Crown, TM. Handel ∕∕ Annu Rev Immu­nol. - 2007. - Vol. 25. - Р. 787-820.

35. Almansa, R. Immunopathogenesis of 2009 pandemic influenza [Text] ∕ R. Almansa, J.F Bermejo-Martin, R.O. De Lejarazu Leonardo ∕∕ Enferm. Infecc. Microbiol. Clin. - 2012. - Vol. 30, Suppl. 4. - P. 18-24.

36. Altered receptor specificity and cell tropism of D222G hemag­glutinin mutants isolated from fatal cases of pandemic A(H1N1)2009 in­fluenza virus ∕ Y. Liu et al. ∕∕ Journal of Virology. 2010. - V.84, № 22. - P. 12069-12074.

37. An under-recognized influenza epidemic identified by rapid in- fiuenza testing, Southern Spi Lanka, 2013 [Text] ∕ L.G. Tillekeratne, T Qstybe, C.K. [et al.] ∕∕ Bodinayake American Journal of Tropical Medicine and Hygiene. - 2015. - Т 92, № 5. - P. 1023-1029.

38. Bedford, T. Global circulation patterns of seasonal influenza vi­ruses vary with antigenic drift [Text] ∕ T. Bedford, S. Riley, I.G. Barr ∕∕ Nature. - 2015. - 523 (7559). - P. 217-220.

39. Benes, J. Scoring systems to evaluate prognosis of community-ac­quired pneumonias [Text] / J. Benes, O. Dzupova, Z. Blechova [et al.] // Vnitr. Lek. - 2012. - Vol. 58, № 5. - P. 357-364.

40. Blood biomarkers for personalized treatment and patient manage­ment decisions in community-acquired pneumonia [Text] / P. Schuetz,

A. Litke, W.C. Albrich [et al.] // Curr. Opin. Infect. Dis. - 2013. - Vol. 26, № 2. - P. 159-167.

41. Boyum, A. Separation of leukocytes from blood and bone mar­row [Text] / A. Boyum // Scand. J. Clin. Lab. Invest. - 1968. - Vol. 21, № 1. - P. 90-109.

42. Brockwell-Staats C. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A(H1N1) [Text] /

C. Brockwell-Staats, R.G. Webster, RJ. Webby // Influenza Respir. Vir. - 2009. - Vol. 3. - P. 207-213.

43. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 in­fluenza viruses [Text] / K. Scheible [et al.] // Vaccine. - 2011. - Vol. 29 (11). - P. 2159-2168.

44. CDC, 2009. Novel Influenza A (H1N1) Virus Infections in Three Pregnant Women - United States, April-May 2009. Centers for Dis­ease Control and Prevention (US) [Text] // MMWR. Morbidity and mortality weekly report. 2009: 58 (18). P. 497-500. Situation Update, 8 January 2014.

45. Can an etiologic agent be identified in adults who are hospital­ized for community-acquired pneumonia: results of a one-year study [Text] / D.M. Musher, I.L. Roig, G. Cazares [et al.] // J. Infect. - 2013. - Vol. 67. - P. 11-18.

46. Cellular immune correlates of protection against symptomatic pandemic influenza [Text] / S. Sridhar [et al.] // Nature Medicine. -

2013. - Vol. 19. - P. 1305-1312.

47. Chakrabarti, A.K. An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses [Text] / A.K. Chakrabarti, G. Pasricha // J. Virol. - 2013. - Vol. 440 (2). - P. 97-104.

48. Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin [Text] /

B. Garcia-Barreno [et al.] // J. Gen. Virol. - 2014. -Vol. 95. - P. 1033-1042.

49. Characterization of the human CD8+ T cell response following in­fection with 2009 pandemic influenza H1N1 virus [Text] / M.L. Hillaire [et al.] // J. Virol. - 2011. - Vol. 85 (22). - P. 12057-12061.

50. Chen, J. The immunobiology of SARS [Text] / J. Chen, K. Sub- barao // Annu RevImmunol. - 2007. - Vol.25. - Р 443-472.

51. Ohoby, B. A. Respiratory infections: community-acquired pneumonia [Text] / B.A. Choby, P. Hunter // F.P. Essent. - 2015. - Vol. 429. - P. 11-21.

52. Clinical and Epidemiologic Characteristics of Hospitalized Patients with 2009 H1N1 Influenza Infection [Text] / S. Nayman Al- pat, G. Usluer, I. Ozgunes [et al.] // Influenza Res Treat. - 2012. - Vol. 23. - P. 1-5.

53. Clinical and virological factors associated with viremia in pan­demic influenza A/H1N1/2009 virus infection [Text] / H. Tse [et al.] // PLoS ONE. - 2011. - Vol. 6 - P. e22534.

54. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection [Text] / N. Hagau [et al.] // Crit. Care Med. - 2010. - Vol. 14 (6). - P. 203.

55. Clinical aspects of pandemic 2009 influenza A/H1N1/ virus infection [Text] / E. Bautista [et al.] // N. Engl. J. Med. - 2010. - Vol. 362. - Р 1708-1719.

56. Clinical features of cases of influenza A (H1N1)v in Osaka prefec­ture, Japan, May 2009 [Text] / N. Komiya, Y. Gu, H. Kamiya [et al.] // Euro Surveill. - 2009. - Vol. 14, № 29. - P. 19272.

57. Combined glucose-6-phosphate dehydrogenase and glucosephos­phate isomerase deficiency can alter clinical outcome [Text] / J.L. Clarke, T.I. Vulliamy, D. Roper [et al.] // Blood Cells Mol. Dis. - 2003. - Vol. 30, № 3. - P. 258-263.

58. Community-acquired pneumonia due to pandemic A (H1N1)2009 influenza virus methicillin resistant staphylococcus aureus co-infection [Text] / RJ. Murray [et al.] // PLoS ONE. - 2010. - Vol. 5(1). - P. 8705.

59. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study [Text] / D. Vi- asus, C. Marinescu, A. Villoslada [et al.] // J. Infect. - 2013. - Vol. 67, № 3. - P. 185-193.

60. Complex formation between malate dehydrogenase and isoci­trate dehydrogenase from Bacillus subtilis is regulated by tricarboxylic

acid cycle metabolites [Text] ∕ M. Bartholomae, F.M. Meyer, F.M. Com- michau [et al.] ∕∕ FEBS J. - 2014. - № 281(4). - Р. 1132-1143.

61. Control of coronavirus infection through plasmacytoid dendritic­cell-derived type I interferon [Text] ∕ L. Cervantes-Barragan, R. Zust,

F. Weber [et al.] ∕∕ Blood. - 2007. - Vol. 109, № 3. - Р. 1131-1137.

62. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses [Text] ∕ S. Gras [et al.] ∕∕ PNAS. - 2010. - Vol. 107 (28). - P. 12599-12604.

63. Cunha, B.A. Swine influenza (H1N1) pneumonia: clinical con­siderations [Text] ∕ B.A. Cunha ∕∕ Infect Dis. Clin. N. Am. - 2010. - № 24. - P. 203-228.

64. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis [Text] ∕ Gao R. [et al.] ∕∕ Am. J. Pathol. - 2013. - Vol. 183. - P. 1258-1268.

65. DeBerardinis, R.J. Cellular metabolism and disease: what do met­abolic outliers teach us? [Text] ∕ RJ. DeBerardinis, C.B. Thompson ∕∕ Cell. - 2012. - Vol. 148, № 6. - P. 1132-1144.

66. De Soli, P. Whole blood chemiluminescence: a new technical ap­proach to assess oxygen-dependent microbial activity of granulocytes [Text] ∕ P. De Soli, S. Lippa, G. Lixxarru ∕∕ J. Clin. Lab. Autom. - 1983. - Vol. 3. - P. 391-400.

67. Dynamic variations in the peripheral blood lymphocyte sub­groups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection [Text] ∕ Xichao Guo, Yu Chen, Xuefen Li, Haishen Kong [et al.] ∕∕ J. Virol. - 2011. - Vol. 8. - P. 1-6.

68. ECDC. Influenza in Europe. Season 2015-2016. [Электронный ресурс]. Режим доступа: httpι∕∕ecdc.europa.eu∕en∕healthtopics∕sea- sonal-influenza∕PublishingImages∕inflιienza-end-of-season-2015-16.jpg.

69. Effects of adjuvants on the safety and immunogenicity of an avi­an influenza H5N1 vaccine in adults [Text] ∕ D.I. Bernstein, K.M. Ed­wards, C.L. Dekker [et al.] ∕∕ J. Infect Dis. - 2008. - Vol. 197, № 5. - P. 667-675.

70. Emergence of a novel swine-origin influenza A (H1N1) virus in humans [Text] ∕ Novel swine-origin influenza A (H1N1) virus investi­gation team; ES. Dawood, S. Jain, L. Finelli [et al.] ∕∕ N Engl J Med. - 2009. -Vol. 360, № 25. - P. 2605-2615.

71. Enhanced epidemiological surveillance of influenza A (H1N1)v in Italy [Text] / C. Rizzo, S. Declich, A. Bella [et al.] // Euro Surveill. - 2009. - Vol.14, № 27. - P. 19266.

72. Endothelial cells are central orchestrators of cytokine amplifi­cation during influenza virus infection [Text] / J.R. Teijaro [et al.] // Cell. - 2011. - Vol. 146. - P. 980-991.

73. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis byrespiratory syncytial virus [Text] / A.E. Alvarez, F.A. Marson, C.S. Bertuzzo [et al.] // J. Pediatr. (Rio J). - 2013. - Vol. 89(6). - P. 531-543.

74. Epidemiology, microbiology, and treatment considerations for bacte­rial pneumonia complicating influenza [Text] / M.L. Metersky, R.G. Master­son, H. Lode [et al.] // Int. J. Infect. Dis. - 2012. - Vol. 16. - P. 321-331.

75. Epidemiology of fatal cases associated with pandemic H1N1 in­fluenza 2009 [Text] / L. Vaillant [et al.] // Eurosurveillance. - 2009. - Vol. 14 (33). - P. 1-6.

76. Epidemiology of influenza A (H1N1)v virus infection in Japan, May - June 2009 [Text] / T Shimada, Y. Gu, H. Kamiya [et al.] // Euro Surveill. - 2009. - Vol. 14, № 24. - P. 19244.

77. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany [Text] / M. Wedde, B. Biere, T Wolff [et al.] // Int J Med Microbiol. - 2015. - T. 305, № 7. - C. 762-75.

78. European Centre for Disease Prevention and Control and the World Health organization Regional Office for Europe [Electronic re­source]. - Mode of access: http://www.pitt.edu/- super 1/lecture/ lec34601/036/htm. (15.04.2012).

79. European Centre for Disease Prevention and Control, Sur­veillance Report, January 8,2010,/ (Электронный ресурс) - Режим доступа: URL: http://ecdc.europa.eu/en/activities/ surveillance/EISN- Newsletter/100108_EISN.

80. Factors associated with death or hospitalization due to pandem­ic 2009 influenza A(H1N1) infection in California [Text] / J. Louie [et al.] // JAMA. - 2009. - Vol. 302. - P. 1896-1902.

81. Factors associated with early hospital discharge of adult influenza patients [Text] / N. Lee, P.K. Chan, K.W Choi [et al.] // Antivir Ther. - 2007. - Vol. 12, № 4. - P. 501-508.

82. Fraser, Pandemic potential of a strain of influenza A(H1N1): early findings [Text] / Fraser C., Donnelly C.A., Cauchemez S. et al. // Sci­ence. - 2009. - Vol. 324. - P. 1557-1561.

83. Francis, T.J. A serological recapitulation of human infection with different strains of influenza virus [Text] / Francis TJ., Davenport F.M., Hennessy A.V. // Trans. Assoc. Am. Phys. 1953, 66: 231-239.

84. Frequency of D222G haemagglutinin mutant of pandem­ic (H1N1) pdm09 influenza virus in Tunisia between 2009 and 2011 [Text] / A.E. Moussi [et al.] // Diagnostic Pathology. - 2013. - Vol. 8 (124). - P. 1-5.

85. Frieman, M. SARS coronavirus and innate immunity [Text] / M. Frieman, M. Heise, R. Baric // Virus Res. - 2008. - Vol. 133, № 1. - Р. 101-112.

86. Fujihashi, K. Mucosal immunosenescence: new developments and vaccines to control infectious diseases [Text] / K. Fujihashi, H. Ki- yono // Trends in immnology. - 2009. - Vol. 30, № 7. - P. 334-343.

87. Functional polymorphisms of interferon-gamma affect pneumo­nia-induced sepsis [Text] / D. Wang [et al.] // PLoS One. - 2014. - Vol. 9. - P. e87049.

88. Functional tumor necrosis factor-related apoptosis-inducing li­gand production by avian influenza virus-infected macrophages [Text] / J. Zhou, H.K. Law, C.Y. Cheung [et al.] // J Infect Dis. - 2006. - Vol. 193, № 7. - P. 945-953.

89. Galvаn, J.M. Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia [Text] / J.M. Galvn, O. Rajas, J. Aspa // Arch Bronconeumol. - 2015. - Vol. 51, № 11. - P. 590-597.

90. Garcia-Souza, L.F. Mitochondria: biological roles in platelet phys­iology and pathology [Text] // L.F. Garcia-Souza, M.F. Oliveira // Int J Biochem Cell Biol. - 2014. - № 50. - Р. 156-160.

91. Gilca, R. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada [Text] / R. Gilca,

G. De Serres // Influenza Other Respi Viruses. - 2011. - Vol. 5(4). - P. 247-255.

92. Glucan microarray analysis of the hemagglutinins from mo­dem and pandemic influenza viruses reveals different receptor specifi­cities [Text] / J. Stevens [et al.] // J. Mol. Biol. - 2006. - Vol. 335. - P. 1143-1155.

93. Glucose-6-phosphate dehydrogenase is regulated through c-Src- mediated tyrosine phosphorylation in endothelial cells [Text] ∕ S. Pan, CJ. World, CJ. Kovacs [et al.] ∕∕ Arterioscler. Thromb. Vasco BioI. -

2009. - Vol. 29, № 6. - P. 895-901.

94. Glutathione depletion reveals impairment of antigen processing and-inhibition of cathepsin activity by nitric oxide in antigen-presenting cells [Text] ∕ G. Lemaire, O. Guittet, M.F. Vesin [et al.] ∕∕ Mol. Immu­nol. - 2009. - Vol. 46, № 6. - P. 1100-1108.

95. Glutathione dysregulation and the etiology and progression of human diseases [Text] ∕ N. Ballatori, S.M. Krance, S. Notenboom [et al.] ∕∕ Biol. Chem. - 2009. - Vol. 390, № 3. - P. 191-214.

96. Gutierrez-Pizarraya, A. Unexpected severity of cases of in­fluenza B infection in patients that require hospitalization duringn the first postpandemic wave [Text] ∕ A. Gutierrez-Pizarraya, P Pi- rez-Romero, R. Alvarez [et al.] ∕∕ J. Inf. - 2012. - Vol. 65(5). - P 423-430.

97. Holoendemic Malaria Exposure Is Associated with Altered Ep­stein-Barr Virus-Specific CD8+ T-Cell Differentiation [Text] ∕ Pratip

K. Chattopadhyay, Kiprotich Chelimo, Paula B. Embury [et al.] ∕∕ J. Vi­rol. - 2013. - Vol. 87, № 3. - P. 1779-1788.

98. Hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009 [Text] ∕ Centers for Disease Control and Prevention ∕∕ MMWR. - 2009. - Vol. 58, № 19. - Р 536-541.

99. Human Cytomegalovirus Induces the Activity and Expression of Acetyl-Coenzyme A Carboxylase, a Fatty Acid Biosynthetic Enzyme Whose Inhibition Attenuates Viral Replication [Text] ∕ Cody M. Spen­cer, Xenia L. Schafer, Nathaniel J. Moorman [et al.] ∕∕ J. Virol. - 2011. - Vol. 85, № 12. - P. 5814-5824.

100. Human infection with new influenza A (H1N1) virus: clini­cal observations from Mexico and other affected countries, May 2009 [Text] ∕ World Health Organization ∕∕ Wkly Epidemiol Rec. - 2009. - Vol. 84, № 21. - P. 185-189.

101. Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009 [Text] ∕ World Health Organization ∕∕ Wkly Epidemiol Rec. - 2009. - Vol.84, № 24. - P. 237-244.

102. Human influenza viruses and CD8+ T Cell responses [Text] / EJ. Grant, S.M. Quinones-Parra, E.B. Clemens, K. Kedzierska // Cur­rent Opinion in Virology. - 2016. - Vol. 16. - P. 132-142.

103. Hypoxia-induced glucose-6-phosphate dehydrogenase overex­pression and -activation in pulmonary artery smooth muscle cells: im­plication in pulmonary hypertension [Text] / S. Chettimada, R. Gupte, D. Rawat [et al.] // Am J Physiol Lung Cell Mol Physiol. - 2015. - № 308(3). - Р. 287-300.

104. Jose, R.J. Community-acquired pneumonia [Text] / R.J. Jose, J.N. Periselneris, J.S. Brown // Curr. Opin. Pulm. Med. - 2015. - Vol. 21, № 3 - Р 212-218.

105. Identification of oxidative stress and Toll-like receptor 4 sign­aling as a key pathway of acute lung injury [Text] / Y. Imai, K. Kuba, G.G. Neely [et al.] // Cell. - 2008. - Vol. 133, № 2. - P. 235-249.

106. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand [Text] / P. Os­ter, J.O’ Hallahan, I. Aaberge [et al.] // Vaccine. - 2007. - Vol. 25, № 16. - P. 3075-3079.

107. Impaired NK cell antiviral cytokine response against influenza virus in small-for-gestational-age neonates [Text] / J. Li [et al.] // Cell. Mol. Immunol. - 2013. - Vol. 10 (5). - P. 437-443.

108. Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha pro­duction in antigen-presenting cells from patients with X-linked agamma­globulinemia [Text] / K. Sochorova, R. Horvath, D. Rozkova [et al.] // Blood. - 2007. - Vol. 109, № 6. - P. 2553-2556.

109. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydro­genase [Text] / G. Cappai, M. Songini, A. Doria [et al.] // Diabetolo- gia. - 2011. - Vol. 54, № 6. - P. 1539-1542.

110. Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein [Text] / B.G. Hale, J. Steel, R.A. Medina [et al.] // J. Virol. - 2010. - Vol. 84, № 14. - P. 6909-6922.

111. Infection and Autoimmunity [Text] / Nancy Agmon Levin, Noel

R. Rose, Y. Shoenfeld. - Gardners Books, 2004. - 768 р.

112. Influenza A (H1N1)pdm09 virus suppresses RIG1 initiated in­nate antiviral responses in the human lung [Text] / W. Wu, W. Zhang,

J.L. Booth, J.P. Metcalf J.P. [et al.] // PLOS ONE. - 2012. - V. 7, № 11. - e49856.

113. Influenza A(H1N1)pdm09: beyond the pandemic [Text] / D. Vi- asus, A. Anton, T Pumarola, J. Carratal // Enferm. Infecc. Microbiol. Clin. - 2012. - Vol. 30, № 4. - P. 54-57.

114. Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell dif­ferentiation [Text] / M.A. Hoeve, A.A. Nash, D. Jackson [et al.] // Plos One. - 2012. - V. 7. - № 1. - e29443.

115. Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 [Text] / D. Zamarin, A. Garcia-Sastre, X. Xiao [et al.] // PLoS Pathog. - 2005. - Vol. 1., № 1. - P. 0040-0054.

116. Influenza virus receptors in the human airway [Text] / K. Shinya, M. Ebina, S. Yamada [et al.] // Nature. - 2006. - Vol. 440. - P. 435-436.

117. Influenza infection and risk of acute pulmonary embolism [Text] / M. Van Wissen, T.T. Keller, B. Ronkes [et al.] // Thromb J. - 2007. - Oct 16, Vol. 5. - Р. 16.

118. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009 [Text] / Centers for Disease Con­trol and Prevention // MMWR. - 2009. - Vol. 58, № 27. - Р 749-752.

119. Interaction of severe acute respiratory syndrome-associated cor­onavirus with dendritic cells [Text] / M. Spiegel, K. Schneider, F. Weber [et al.] // J Gen Virol. - 2006. - Vol. 87, № 7. - P. 1953-1960.

120. In vitro and in vivo characterization of new swine-origin H1N1 influenza virus [Text] / Y. Itoh, K. Shinya, M. Kiso [et al.] // Nature. - 2009. - Vol. 460, № 7258. - P. 1021-1025.

121. Kash, J.C. The Role of Viral, Host, and Secondary Bacterial Fac­tors in Influenza Pathogenesis [Text] / J.C. Kash, J.K. Taubenberger // Am. J. Pathol. - 2015. - Vol. 185, № 6. - P. 1528-1536.

122. Kauffman, KJ. Advances in flux balance analysis [Text] / KJ. Kauffman, P. Prakash, J.S. Edwards // Current Opinion in Biotech­nology. - 2003. - Vol. 14, № 5. - P. 491-496.

123. Killip, M.J. Influenza virus activation of the interferon system [Text] / M.J. Killip, R.E. Randall, E. Fodor // Virus Research. - 2015. - Vol. 209. - P. 11-22.

124. Kotzamanis, K. Infection homeostasis: implications for thera­peutic and immune programming of metabolism in controlling infection

[Text] ∕ K. Kotzamanis, A. Angulo, P. Ghazal1 ∕∕ Med. Microbiol. Immu­nol. - 2015. - Vol. 204, № 3. - P. 395-407.

125. Kuiken T. Pathology of human influenza revisited ∕ T. Kuiken, J. Taubenberger ∕∕ Vaccine. - 2008. - Vol. 26. - P. 59-66.

126. Lacoma, A. Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores [Text] ∕ A. Lacoma, A. Bas, P. Tudela [et al.] ∕∕ Enferm. Infecc. Microbiol. Clin. - 2014. - Vol. 32, № 3. - P. 140-146.

127. Lai, C. Cytokines Network and Influenza Virus Infection [Text] ∕ C. Lai, X. Wang, P. Yang ∕∕ Clin. Microbial. - 2014. - Vol. 3 (147). - dok10.4172∕2327-5073.1000147.

128. Levinson, W. Review of Medical Microbiology and Immunology [Text] ∕ W. Levinson. - McGraw-Hill, 2010. - 640 p.

129. Liderot, K. Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1 [Text] ∕ K. Liderot, M. Ahl, V. Ozenci ∕∕ Biomed Res Int. - 2013. - Vol. 6. - P. 1-6.

130. Littleton, S.W Impact of obesity on respiratory function [Text] ∕

S.W. Littleton ∕∕ Respirology. - 2012. - Vol. 17, № 1. - P. 43-49.

131. Longo, D.L. Community-acquired pneumonia [Text] ∕ D.L. Lon­go ∕∕ N. Engl. J. Med. - 2014. - Vol. 371. - P. 1619-1628.

132. Manchini, G. Immunochemical quantitation of antigens by sin­gle radial diffusion [Text] ∕ G. Manchini, A.O. Carbonaro, J.F. Hare­mans ∕∕ Immunochemistry. - 1965. - Vol. 2, № 3. - P. 235-255.

133. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites [Text] ∕ S. Mauerer-Stroh, J. Ma, R. Tze Chuen Lee [et al.] ∕∕ Biology Direct. - 2009. - Vol. 4, № 5. - P. 1-9.

134. Marti, C. Prediction of severe community-acquired pneu­monia: a systematic review and meta-analysis [Text] ∕ C. Marti, N. Garin, O. Grosgurin [et al.] ∕∕ Crit. Care. - 2012. - Vol. 27, № 16. - P. 141.

135. Matrix protein 2 of influenza A virus blocks autophagosome fu­sion with lysosomes [Text] ∕ Gannage M., Dormann D., R. Albrecht [et al.] ∕∕ Cell. Host. Microbe. - 2009. - Vol. 6. - P. 367-380.

136. Membrane Accumulation of Influenza A Virus Hemaggluti­nin Triggers Nuclear Export of the Viral Genome via Protein Kinase C- mediated Activation of ERK Signaling [Text] ∕ H. Marjuki, M.I. Alam,

C. Ehrhardt [et al.] // J. Biol. Chem. - 2006. - Vol. 281, № 24. - P. 16707-16715.

137. Memory CD4+ T cells protect against influenza through mul­tiple synergizing mechanisms [Text] / K.K. McKinstry [et al.] // J. Clin. Invest. - 2012. - Vol. 122. - P. 2847-2856.

138. Min J.-Y. The primary function of RNA binding by the influ­enza A virus NS1 protein in infected cells: Inhibiting the 2,,5,-oligo(A) synthetase [Text] / J.-Y. Min, R.M. Krug // Proc Natl Acad Sci USA. - 2006. - Vol. 103, № 18. - P. 7100-7105.

139. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV [Text] / T Sheahan, T.E. Morrison,W. Funk­houser [et al.] // PLoS Pathog. - 2008. - Vol. 4, № 12. - P. e1000240.

140. Nelson, M.I. Reverse zoonosis of influenza to swine: new per­spectives on the human-animal interface [Text] / M.I. Nelson, A.L Vin­cent. // Trends Microbiol. - 2015. - 23 (3). - P. 142-53.

141. Neuraminidase and hemagglutinin matching patterns of a nighly pathogenic avian and two pandemic H1N1 influenza a viruses [Text] / Y. Zhang [et al.] // PLoS One. - 2010. - № 5(2). - P. 9167.

142. New horizon of mucosal immunity and vaccines [Text] / I. Taka­hashi, T. Nochi, Y. Yuri // Current opinion in immunologt. - 2009. - Vol. 21. - P. 352-358.

143. New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases [Text] / M. Liang, D.C. Lye, M.I. Chen [et al.] // Singa­pore Med J. - 2009. -Vol. 50, № 6. - P. 581-583.

144. Novel pandemic influenza A (H1N1) virus infection modulates apoptotic pathways that impact its replication in A549 cells [Text] / X. Wang [et al.] // Microbes Infect. - 2014. - Vol. 16 (3). - P. 178-186.

145. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A (H1N1) virus and severe clinical out­come, Norway 2009-2010 [Text] / A. Kilander [et al.] // Euro Surveill. -

2010. - Vol. 15, № 9.

146. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009 [Text] / Centers for Disease Control and Prevention (CDC) // MMWR. - 2009. - Vol. 58, № 17. - Р. 467-470.

147. Pandemic H1N1 Influenza. Pathology and Pathogenesis of 100 Fatal Cases in the United States [Text] / WJ. Shieh [et al.] //

AJ. Pathol. - 2010 - Vol. 177. - P. 166-175.

148. Pandemic H1N1 Chronology, August 2009, (Электронный ресурс) - Режимдоступа: URL: http://www.wpro.who.int/NR/rdon- lyres/ 18DB2FA5-5BE0-422B-B0FD-826 C5DD1 D7BD/0/Pan- demicH1N1_ Chronology_Aug09.pdf.

149. Pandemic (H1N1) 2009, Pan American Health Organization, 2009, (Электронный ресурс) - Режим доступа: URL: http://new.paho. org/hq/images/atlas/en/atlas.html.

150. Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009-2010 / A. Bal, V. Suri, B. Mishra [et al.] // Histopathology. - 2012. - Vol. 60. - P. 326-335.

151. Pathogenesis of influenza-induced acute respiratory distress syn­drome [Text] / K.R. Short, E.J. Kroeze, R.A. Fouchier [et al.] // Lancet Infect Dis. - 2014. - Vol. 14(1). - P. 57-69.

152. PB1-F2 influenza a virus protein adopts a beta-sheet confor­mation and forms amyloid fibers in membrane environments [Text] / C. Chevalier, A. Al Bazzal, J. Vidic [et al.] // J. Biol. Chem. - 2010. - Vol. 2815, № 2. - P. 13233-13243.

153. Replication and pathogenesis of the pandemic (H1N1) 2009 in­fluenza virus in mammalian models [Text] / D. Kwon, K. Shin, S. Kim [et al.] // J. Microbiol. - 2010. - V. 48. - P. 657-662.

154. Peteranderl, C. Human influenza virus infections [Text] / C. Pe- teranderl, S. Herold, C. Schmoldt // Seminars in Respiratory and Criti­cal Care Medicine. - 2016. - Vol. 37, № 4. - P. 487-500.

155. Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection [Text] / Y.C.F. Su, J. Bahl, U. Joseph [et al.] // Nature Communications. - 2015. - Vol. 6. - P. 7952.

156. Pliyev, B.K. Extracellular NAD(+) inhibits human neutrophil apoptosis [Text] / B.K. Pliyev, A.V. Ivanova, V.G. Savchenko // Apopto­sis. - 2014. -Vol. 19, № 4. - P. 581-593.

157. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico [Text] / R. Perez-Padilla, D. de la Rosa-Zamboni, S. Ponce de Leon [et al.] // N Engl J Med. - 2009.-Vol. 361, № 7. - P. 680-689.

158. Preparing for the second wave: lessons from current out­breaks, 28 august 2009, WHO Pandemic (H1N1) briefing note 09,(Электронныйресурс) - Режимдоступа:URL:http://www.who.

int∕csr∕disease∕swineflu∕notes∕h1n1-second-wave-20090828∕ en∕index.html.

159. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [Text] ∕ A.E. Fiore, D.K. Shay, K. Broder [et al.] ∕∕ MMWR. - 2008. - Vol. 57, № RR-7. - Р. 1-60.

160. Primary T cell expansion and differentiation in vivo requires an­tigen presentation by B cells [Text] ∕ A. Crawford, M. Macleod, T Schu­macher [et al.] ∕∕ J Immunol. - 2006. - Vol. 176, № 6. - Р. 3498-3506.

161. Public Health Agency of Canada, weekly reports, 2008-2009 (week 34), (Электронный ресурс) - Режим доступа: URL: http√∕ www.phac-aspc.gc.ca∕fluwatch∕08-09∕w34-09∕index-eng. php.

162. Public Health Agency of Canada, weekly reports, 2009-2010 (week48), (Электронныйресурс) - Режимдоступа: URLιhttpι∕∕www. phacaspc.gc.ca∕fluwatch∕09-10∕w48-09∕index-eng.php.

163. Raman, K. Flux balance analysis of biological systems: applica­tions and challenges [Text] ∕ K. Raman, N. Chandra ∕∕ Briefings in Bio­informatics. - 2009. - Vol. 10, № 4. - P. 435-449.

164. Rello, J. Clinical review: primary influenza viral pneumonia [Text] ∕ J. Rello, A. Pop-Vicas ∕∕ Crit Care. - 2009. - № 13(6). - P. 235

165. Resperatory disease in adults during pandemic (H1N1) 2009 outbreak, Argentina [Text] ∕ Zala C. [et al.] ∕∕ Emerg. Infect. Dis. - 2009. - Vol. 15, № 12. - P. 2060-2061.

166. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine [Text] ∕ H.W. Kim, J.G. Canchola, C.D. Brandt [et al.] ∕∕ Am. J. Epidemiol. - 2009. - Vol. 89, № 4. - P. 422-434.

167. Role for innate IFNs in determining respiratory syncytial vi­rus immunopathology [Text] ∕ T.R. Johnson, S.E. Mertz, N. Gitiban [et al.] ∕∕ J. Immunol. - 2005. - Vol. 174, № 11. - P. 7234-7241.

168. Role of human Toll-like receptors in naturally occurring influ­enza infections ∕ N. Lee, C.K. Wong, D.S. Hui [et al.] ∕∕ Influenza other Respir. viruses. - 2013. - V. 7. - № 5. - P. 666-675.

169. Role of IgA versus IgG in the control of influenza viral infec­tion in the murine respiratory tract [Text] ∕ K.B. Renegar, P.A. Small,

L. G. Boykins [et al.] ∕∕ J. Immunol. - 2004. - Vol. 173, № 12. - P. 1978-1986.

170. Role of sialic acid binding specificity of the 1918 influenza vi­rus hemagglutinin protein in virulence and pathogenesis for mice [Text] /

L. Qi [et al.] // J. Virol. - 2009. - Vol. 83, № 8. - P. 3754-3761.

171. Rozenbaum, M.H. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults: a meta-analysis [Text] /

M. H. Rozenbaum, P. Pechlivanoglou, T.S. van der Werf // Eur. J. Clin. Microb. Infect. Dis. - 2013. - Р. 305-316.

172. Sant, AJ. Revealing the role of CD4(+) T cells in viral immuni­ty [Text] / AJ. Sant, A. McMichael // J. Exp. Med. - 2012. - Vol. 209. - P. 1391-1395.

173. Severity of influenza A 2009 (H1N1) pneumonia is underesti­mated by routine prediction rules. Results from a prospective, popula­tion-based study [Text] / A. Bjarnason, G. Thorleifsdottir, A. Lоve [et al.] // PLoS One. - 2012. - Vol. 7(10). - Р. e46816.

174. Stanton, R.C. Glucose-6-Phosphate Dehydrogenase, NADPH, and Cell Survival [Text] / R.C. Stanton // IUBMB Life. - 2012. - Vol. 64, № 5. - P. 362-369.

175. Structure of NADP(+)-dependent glutamate dehydroge­nase from Escherichia coli-refl ections on the basis of coenzyme specifi city in the family of glutamate dehydrogenases [Text] / M. ASharkey, T. FOliveira, P.C. Engel [et al.] // FEBS J. - 2013. - № 280(18). - Р 4681-4692.

176. Substantial Morbidity and Mortality Associated with Pandem­ic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity [Text] / J. Dаvila, G. Chowell, V.H. Borja-Aburto [et al.] // PLoS Curr. - 2014. - № 6. - P. 1-14.

177. Summary of situation of Pandemic (H1N1) 2009, (Электронный ресурс) - Режим доступа: URL: http://www. searo.who. int/EN/ Sec­tion 10/Section2562.htm.

178. Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009 [Text] / Centers for Disease Control and Pre­vention // MMWR. - 2009. - Vol. 58, № 17. - Р. 470-472.

179. Synthesis and anti-influenza a virus activity of 6'-amino-6'- deoxy-glucoglycerolipids analogs [Text] / L. Ren, J. Zhang, H. Ma [et al.] // Marine Drugs. - 2016. - Vol. 14, № 6. - P. 116.

180. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese [Text] /

M.W. Ng, G. Zhou, W.P. Chong [et al.] // BMC Infect Dis. - 2007 - Vol. 7. - P. 50.

181. The fate of influenza A virus infection of human macrophages and dendritic cells / K.R. Short, A.G. Brooks, P.C. Reading [et al.] // J. General Virology. - 2012. - V. 93. - P. 2315-2325.

182. The Influenza virus resource at the National Center for Biotech­nology Information [Text] / Y. Bao, P. Bolotov, D. Dernovoy [et al.] // J. of Virology. - 2008. - Vol. 82, № 2. - P. 596-601.

183. The state of specific humoral immunity in the system «mother- newborn» in women who suffered influenza A(H3N2) in different trimes­ters of pregnancy [Text] / М.Т. Lutsenko, I.N. Gorikov, BA. Rabinovich [et al.] // The 9th Sino-Russia Forum of Biomedical and Pharma-ceutical Forum. Harbin, China, 2012. - P. 280-281

184. Torres, A. Biomarkers and community-acquired pneumonia: tailoring management with biological data [Text] / A. Torres, P. Ram­irez, B. Montull // Semin. Respir. Crit. Care Med. - 2012. - Vol. 33, № 3. - P. 266-271.

185. Torres, A. The aetiology and antibiotic management of commu­nity-acquired pneumonia in adults in Europe: a literature review [Text] / A. Torres, F. Blasi, W.E. Peetermans // Eur. J. Clin. Microbiol. Infect. Dis. - 2014. - Vol. 33. - P. 1065-1079.

186. Trends for influenza-related deaths during pandemic and epi­demic seasons, Italy, 1969-2001 [Text] / C. Rizzo, A. Bella, C. Viboud [et al.] // Emerg. Infect. Dis. - 2007. - Vol. 13, № 5. - P. 694-699.

187. Tumoricidal activity of TLR7/8-activated inflammatory den­dritic cells [Text] / G. Stary, C. Bangert, M. Tauber [et al.] // J Exp Med. - 2007. - Vol. 204, № 6. - P. 1441-1451.

188. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009 [Text] / Centers for Disease Control and Preven­tion // MMWR (Morb Mortal Wkly Rep). - 2009. - Vol. 58, № 16. - Р. 433-435.

189. Van der Werf, S. Influenza - the need to stay ahead of the virus [Text] / S. Van der Werf, D. Levy-Bruhl // Eurosurveillance. - 2015. - Vol. 20, № 5. - P. 1-4.

190. Wang, Z. Avian influenza viruses, inflammation, and CD8+ T cell immunity [Text] / Z. Wang, L. Loh, L. Kedzierski // Frontiers in Im­munology. - 2016. - Vol. 7. - P 60.

191. Weekly Epidemiological Monitor, November 2009, 2(44). (Электронныйресурс - Режимдоступа: http://www.emro. who.int/ csr/h1n1/pdf/epi_monitor_44_09.pdf (дата обращения: 18.12.2009 г.).

192. WHO. Antigenic and genetic characteristics of zoonotic influ­enza viruses and development of candidate vaccine viruses for pandemic preparedness [Электронный ресурс] // Sept. 2015. - Режим доступа: http://www.who.int/influenza/vaccines/virus/201509_zoonotic_vac- cinevirusupdate.pdf?ua=1.

193. WHO. 2009. Pandemic (H1N1) 2009-update 64. / World Health Organization. Situation Update, 8 January 2014. http://www. who.int/csr/don/2010_05_28/en/index.html.

<< | >>
Источник: Сергеева И.В., Демко И.В.. Особенности течения гриппа и вирусно-бактериальных пневмоний (по материалам многопрофильных стационаров г. Красноярска): монография. - М.,2017. - 179 с.. 2017

Еще по теме СПИСОК ЛИТЕРАТУРЫ:

  1. СПИСОК ЛИТЕРАТУРЫ
  2. СПИСОК ЛИТЕРАТУРЫ
  3. Список литературы:
  4. Список литературы
  5. СПИСОК ЛИТЕРАТУРЫ
  6. СПИСОК ЛИТЕРАТУРЫ
  7. СПИСОК ЛИТЕРАТУРЫ
  8. Список литературы
  9. СПИСОК ЛИТЕРАТУРЫ:
  10. Список литературы
  11. Список литературы
  12. СПИСОК ЛИТЕРАТУРЫ
  13. СПИСОК ЛИТЕРАТУРЫ
  14. СПИСОК ЛИТЕРАТУРЫ
  15. Список литературы
  16. СПИСОК ЛИТЕРАТУРЫ
  17. Список литературы
  18. Список литературы
  19. Список литературы
  20. Список литературы